Category: Psychedelics
-
BioNxt Solutions (BNXT.C) to spark marketing as ODF human studies begin
Biotech companies are notoriously difficult to find investor love for in Canada, at least historically, so it’s no surprise that BioNxt Solutions (BNXT.C) is headquartered in Germany. That proximity to German investors is likely to come in handy as the company seeks to start cranking out marketing coverage after several months of prepping their Oral…
-
Lophos Pharma (MESC.C) now readies for natural and synthetic peyote production
Lophos Pharmaceuticals Corp. (MESC.C), a key player in the Canadian biosciences/psychedelics sector, has made a significant leap forward in the field of psychoactive compound research and development as it has announced the successful finalization of a new synthetic mescaline production protocol, marking a major milestone in the accessibility and study of psychoactive substances. This development…
-
Peyote at the ready: Lophos Holdings (MESC.C) expands license, lays out product specs
What a time to be alive; there was a period in our civilized history where getting alcohol on a Sunday was a tough racket, now we’re exploring the safe supply of cocaine, goverment sold weed, prescribed MDMA, magic mushroom microdosing and, increasingly, the wondrous powers of peyote being safely available to those who partake. It…
-
![Stocks go green as Deloitte predicts spring rate cut 01-04-23]()
Stocks go green as Deloitte predicts spring rate cut 01-04-23
The TSX bumped 56.43 to 20875.01. TSX Venture moved up 1.11 to 551.18 while the CSE Composite edged higher to 170.32. There was a sense of positivity in the markets after Deloitte Canada predicted BoC would cut rates in the spring and even though H1 will see stagnant growth as a hangover from last years…
-
![Optimi Health (OPTI.C) transforming psychedelic treatment and wellness]()
Optimi Health (OPTI.C) transforming psychedelic treatment and wellness
In Canada, the prevalence of depression and mental health disorders has shown a worrying increase. According to data from 2022, over 5 million Canadians, accounting for 18% of the population aged 15 and older. This growing trend underscores the importance of addressing mental health issues at a societal and policy level, with an emphasis on…
-
![Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets]()
Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets
Several years back, Hugh Rogers was in my office talking about his cannabis company. Way back then, the plan was to grow in Germany and be first on the continent, using an old wartime bunker as a ‘safe growing facility’. Those plans morphed quickly as the reality of the cannabis space became clear. The cannabis…
-
![Lophos Pharmaceuticals (MESC.C) expands licensing to include just about all the drugs]()
Lophos Pharmaceuticals (MESC.C) expands licensing to include just about all the drugs
There’s no better due diligence in the psychoactive drug space than Health Canada. Loads of pharma companies have investor decks that promise they’ll one day be in the psychedelics business, the MDMA business, even mescaline, but getting licensed to be involved in those spaces is not an easy thing. Lophos Pharmaceuticals Corp (MESC.C) recently received…
-
![Revive Therapeutics (RVV.C) finds multiple research options moving forward]()
Revive Therapeutics (RVV.C) finds multiple research options moving forward
In Canada, if you look backwards over the timeline, you’ll often find public companies have been other things back in the day. Risen, fallen, tapped out, rolled back, reemerged as a whole new thing. Sometimes this happens several times before a business model catches. Revive Therapeutics (RVV.C) is that rare Canadian smallcap that, while it…
-
![Cannabis memory lane: Who’s sticking it out, who’s dead and dying]()
Cannabis memory lane: Who’s sticking it out, who’s dead and dying
I was feeling every ounce of my chest cold, the thing everyone apparently has, the one that’s going around, the one that’s not covid but who could tell. I was also standing on a stage at the Richmond Chamber of Commerce awards gala, blinking at stage lights and peaking over the shoulders of some very…
-
![Lucy Loves Luchre: Psyence Group (PSYG.C) was always just a shroom chaser]()
Lucy Loves Luchre: Psyence Group (PSYG.C) was always just a shroom chaser
The boss has told me to start running the rule over weed and psychedelics companies with a view to picking out anything that’s quietly profitable, or could be soon, among the general dross of both sectors, and to say I’m excited by that would be an overstatement. In general, cannabis companies are hamstrung by government…
